Literature DB >> 24234558

Counseling and screening for cystic fibrosis in patients with congenital bilateral absence of the vas deferens: Patient perceptions.

J L Fitzpatrick1, E M Hutton, R Babul, C S Cytrynbaum, J E Sutherland, C T Shuman.   

Abstract

Congenital bilateral absence of the vas deferens (CBAVD) occurs in approximately 1.3% of infertile males and is thought to be, in most cases, a primarily genital form of cystic fibrosis (CF). Fourteen males with CBAVD considering microsurgical sperm aspiration from the epididymis (MESA) and in vitro fertilization were seen for genetic counseling and screening for CF. To retrospectively evaluate these patients' perceptions of the counseling and screening information, we conducted structured telephone interviews to assess their recall of information about CF and its impact on their health concerns and reproductive plans. We found that, as the health implications of CF are abstract and not as important to patients as the diagnosis of CBAVD itself, patients tend to view their CF status primarily in terms of their reproductive potential. Retrospective analysis afforded us an opportunity to identify the psychosocial issues of most concern to this unique patient population.

Entities:  

Year:  1996        PMID: 24234558     DOI: 10.1007/BF01408661

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  24 in total

1.  Amniocentesis in the context of infertility.

Authors:  M Sandelowski; B G Harris; D Holditch-Davis
Journal:  Health Care Women Int       Date:  1991 Apr-Jun

2.  Attitudes towards prenatal diagnosis and carrier screening for cystic fibrosis among the parents of patients in a paediatric cystic fibrosis clinic.

Authors:  E K Watson; J Marchant; A Bush; B Williamson
Journal:  J Med Genet       Date:  1992-07       Impact factor: 6.318

3.  Prenatal cystic fibrosis carrier testing: designing an information leaflet to meet the specific needs of the target population.

Authors:  M E Mennie; W A Liston; D J Brock
Journal:  J Med Genet       Date:  1992-05       Impact factor: 6.318

4.  New treatment for infertility due to congenital absence of vas deferens.

Authors:  S Silber; T Ord; C Borrero; J Balmaceda; R Asch
Journal:  Lancet       Date:  1987-10-10       Impact factor: 79.321

5.  The impact of population based screening for carriers of cystic fibrosis.

Authors:  H Bekker; G Denniss; M Modell; M Bobrow; T Marteau
Journal:  J Med Genet       Date:  1994-05       Impact factor: 6.318

6.  Infertility and the physician--patient relationship: a biopsychosocial challenge.

Authors:  D G Hertz
Journal:  Gen Hosp Psychiatry       Date:  1982-07       Impact factor: 3.238

7.  Human pregnancy by in vitro fertilization (IVF) using sperm aspirated from the epididymis.

Authors:  P D Temple-Smith; G J Southwick; C A Yates; A O Trounson; D M de Kretser
Journal:  J In Vitro Fert Embryo Transf       Date:  1985-09

Review 8.  Congenital bilateral absence of the vas deferens and cystic fibrosis. A genetic commonality.

Authors:  R D Oates; J A Amos
Journal:  World J Urol       Date:  1993       Impact factor: 4.226

9.  Psychosocial, treatment, and demographic predictors of the stress associated with infertility.

Authors:  A Abbey; L J Halman; F M Andrews
Journal:  Fertil Steril       Date:  1992-01       Impact factor: 7.329

10.  A preliminary trial of couple screening for cystic fibrosis: designing an appropriate information leaflet.

Authors:  J Livingstone; R A Axton; M Mennie; A Gilfillan; D J Brock
Journal:  Clin Genet       Date:  1993-02       Impact factor: 4.438

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.